Literature DB >> 27578606

Review of drug utilization patterns in NICUs worldwide.

N Krzyżaniak1, I Pawłowska2, B Bajorek3.   

Abstract

WHAT IS KNOWN AND
OBJECTIVES: When considering acute care settings, such as the neonatal intensive care unit (NICU), the inappropriate use of medicines poses a great risk to vulnerable babies at the start of their lives. However, there is limited published literature that explores the current medication management practices in NICUs and where the main misuse issues lie. Therefore, the purpose of this review was to give an overview of medicine use in NICUs worldwide and identify therapeutic areas requiring more targeted pharmaceutical care. Specific objectives include the following: identifying the most commonly used medicines, comparing these to the A-PINCH (Anti-infectives, Potassium and other electrolytes, Insulin, Narcotics and sedatives, Chemotherapy agents, Heparin and other anticoagulants), high-risk medicines list, and determining whether there are any differences in medicine use between countries.
METHOD: Quasi-systematic literature review. SEARCH STRATEGY: Google Scholar, MEDLINE/PubMed, Scopus and EMBASE were searched utilizing selected MeSH terms.
RESULTS: A total of 19 articles from 12 countries were reviewed. Medication use between countries was very similar with no discernible differences in types of medicines prescribed. The most commonly used medicines included gentamicin, ampicillin, caffeine, furosemide and vitamin K. The median number of medicines prescribed per patient ranged from 3 to 11, and an inverse relationship was identified between gestational age and the number of medications that were prescribed. Nine of the 20 most commonly used medicines were listed as A-PINCH medicines, and included antibiotics, fentanyl, morphine and heparin. Inappropriate prescribing, as well as the high use of off-label/unlicensed medicines, was highlighted as areas of practice that require consideration to improve medication safety and minimize the potential risk for medication errors. WHAT IS NEW AND
CONCLUSION: Overall, the types of medicines used in NICUs worldwide are similar, with consistent reports on the common use of antibiotics, caffeine and vitamins. However, it cannot be definitively stated that the findings of the review accurately depict current practice in NICUs, due to the limited amount of published literature available. There are several areas of concern that warrant further investigation to improve rational use of medicines in the neonatal populations, including high use of antibiotics and off-label and unlicensed medicines.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  NICU; drug utilization; neonate; prescription patterns

Mesh:

Year:  2016        PMID: 27578606     DOI: 10.1111/jcpt.12440

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  17 in total

Review 1.  Management of thrombosis in children and neonates: practical use of anticoagulants in children.

Authors:  Paul Monagle; Fiona Newall
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Neonatal Programming of Microbiota Composition: A Plausible Idea That Is Not Supported by the Evidence.

Authors:  Catherine Michel; Hervé M Blottière
Journal:  Front Microbiol       Date:  2022-06-17       Impact factor: 6.064

3.  The role of the clinical pharmacist in the NICU: a cross-sectional survey of Australian and Polish pharmacy practice.

Authors:  Natalia Krzyżaniak; Iga Pawłowska; Beata Bajorek
Journal:  Eur J Hosp Pharm       Date:  2018-01-20

4.  Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.

Authors:  Marine Butin; Frédéric Laurent; Thierry Wirth; Marine Bergot; Jean-Philippe Rasigade; Bruno Pichon; Maxime Barbier; Patricia Martins-Simoes; Laurent Jacob; Rachel Pike; Pierre Tissieres; Jean-Charles Picaud; Angela Kearns; Philip Supply
Journal:  Nat Microbiol       Date:  2020-04-27       Impact factor: 17.745

Review 5.  Use of diuretics in the neonatal period.

Authors:  Jean-Pierre Guignard; Silvia Iacobelli
Journal:  Pediatr Nephrol       Date:  2021-01-22       Impact factor: 3.714

6.  Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit.

Authors:  A Girardi; S Galletti; E Raschi; A Koci; E Poluzzi; G Faldella; F De Ponti
Journal:  Ital J Pediatr       Date:  2017-04-17       Impact factor: 2.638

7.  Furosemide use in Italian neonatal intensive care units: a national survey.

Authors:  Valeria Anna Manfredini; Chiara Cerini; Antonio Clavenna; Andrea Dotta; Maria Letizia Caccamo; Alex Staffler; Luca Massenzi; Rossano Massimo Rezzonico
Journal:  Ital J Pediatr       Date:  2020-06-22       Impact factor: 2.638

8.  Potential drug incompatibilities in the neonatal intensive care unit: a network analysis approach.

Authors:  Ramon Weyler Leopoldino; Haline Tereza Costa; Tatiana Xavier Costa; Rand Randall Martins; António Gouveia Oliveira
Journal:  BMC Pharmacol Toxicol       Date:  2018-12-06       Impact factor: 2.483

9.  Comparison of antibiotic dosing recommendations for neonatal sepsis from established reference sources.

Authors:  T B Y Liem; E M A Slob; J U M Termote; T F W Wolfs; A C G Egberts; C M A Rademaker
Journal:  Int J Clin Pharm       Date:  2018-01-16

10.  Cross-sectional study of drug utilisation in a Chinese neonatal unit.

Authors:  Yan Yue; Libin Chen; Imti Choonara; Tao Xiong; Shalini Ojha; Jun Tang; Yan Wang; Linan Zeng; Jing Shi; Hua Wang; Dezhi Mu
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.